GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embla Medical hf (OCSE:EMBLA) » Definitions » PS Ratio

Embla Medical hf (OCSE:EMBLA) PS Ratio : 2.24 (As of May. 12, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Embla Medical hf PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Embla Medical hf's share price is kr29.00. Embla Medical hf's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was kr12.97. Hence, Embla Medical hf's PS Ratio for today is 2.24.

Good Sign:

Embla Medical hf stock PS Ratio (=2.24) is close to 10-year low of 2.06

The historical rank and industry rank for Embla Medical hf's PS Ratio or its related term are showing as below:

OCSE:EMBLA' s PS Ratio Range Over the Past 10 Years
Min: 1.42   Med: 3.3   Max: 5.17
Current: 2.24

During the past 13 years, Embla Medical hf's highest PS Ratio was 5.17. The lowest was 1.42. And the median was 3.30.

OCSE:EMBLA's PS Ratio is ranked better than
62.66% of 806 companies
in the Medical Devices & Instruments industry
Industry Median: 3.28 vs OCSE:EMBLA: 2.24

Embla Medical hf's Revenue per Sharefor the three months ended in Mar. 2024 was kr3.15. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was kr12.97.

Good Sign:

Embla Medical hf has shown predictable revenue and earnings growth.

During the past 12 months, the average Revenue per Share Growth Rate of Embla Medical hf was 5.70% per year. During the past 3 years, the average Revenue per Share Growth Rate was 11.90% per year. During the past 5 years, the average Revenue per Share Growth Rate was 6.00% per year. During the past 10 years, the average Revenue per Share Growth Rate was 7.90% per year.

During the past 13 years, Embla Medical hf's highest 3-Year average Revenue per Share Growth Rate was 27.90% per year. The lowest was 0.40% per year. And the median was 8.80% per year.

Back to Basics: PS Ratio


Embla Medical hf PS Ratio Historical Data

The historical data trend for Embla Medical hf's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Embla Medical hf PS Ratio Chart

Embla Medical hf Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.81 5.32 3.78 2.78 2.15

Embla Medical hf Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.52 2.56 2.26 2.15 2.58

Competitive Comparison of Embla Medical hf's PS Ratio

For the Medical Devices subindustry, Embla Medical hf's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Embla Medical hf's PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Embla Medical hf's PS Ratio distribution charts can be found below:

* The bar in red indicates where Embla Medical hf's PS Ratio falls into.



Embla Medical hf PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Embla Medical hf's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=29.00/12.974
=2.24

Embla Medical hf's Share Price of today is kr29.00.
Embla Medical hf's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr12.97.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Embla Medical hf  (OCSE:EMBLA) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Embla Medical hf PS Ratio Related Terms

Thank you for viewing the detailed overview of Embla Medical hf's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Embla Medical hf (OCSE:EMBLA) Business Description

Traded in Other Exchanges
Address
Grjothals 5, Reykjavik, ISL
Ossur hf is engaged in the design, development, manufacture, and sale of prosthetics and bracing & support products. The company's products improve mobility through technologies in the field of braces, supports, prosthetic limbs, and compression therapy. Its segments are the Bracing & Supports and Prosthetics segment. The bracing & support products are used to support joints and other body parts for therapeutic and preventative purposes. The Prosthetics segment includes artificial limbs and related products for individuals born without limbs. Its geographical segments are the Americas; Europe, the Middle East & Africa (EMEA); and the Americas & Asia-Pacific (APAC), of which the Americas generate nearly half of the company's revenue.

Embla Medical hf (OCSE:EMBLA) Headlines

No Headlines